Arrow Mark Colorado Holdings LLC Nex Immune, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.21 - $18.5 $201,202 - $17.7 Million	-958,105 Reduced 98.87%	10,924 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $214,208 - $6.25 Million	-357,014 Reduced 26.92%	969,029 $537,000
Q1 2022 May 16, 2022	SELL	$1.79 - $4.65 $854,168 - $2.22 Million	-477,189 Reduced 26.46%	1,326,043 $5.58 Million
Q4 2021 Feb 14, 2022	SELL	$4.11 - $15.13 $639,437 - $2.35 Million	-155,581 Reduced 7.94%	1,803,232 $8.31 Million
Q3 2021 Nov 15, 2021	SELL	$10.32 - $16.9 $6.08 Million - $9.96 Million	-589,180 Reduced 23.12%	1,958,813 $29.7 Million
Q2 2021 Aug 16, 2021	SELL	$14.98 - $23.89 $668,587 - $1.07 Million	-44,632 Reduced 1.72%	2,547,993 $2.13 Million
Q1 2021 May 17, 2021	BUY	$17.95 - $25.91 $46.5 Million - $67.2 Million	2,592,625 New	2,592,625 $49.5 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $2.42M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.